Retatrutide/Cagrilintide

Weight Loss

10Vendors

Ultra-aggressive fat-loss stack aimed at maximum appetite control and faster scale changes. This is largely a community-built combo rather than a formally studied product pairing.

Studies
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.	PubMed
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.	PubMed
Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.	PubMed

Retatrutide/Cagrilintide Vendors
Ameano Peptides 0.0	Profile
EZ Peptides 0.0	Profile
Flawless Compounds 0.0	Profile
Glacier Aminos 0.0	Profile
Glow Aminos 0.0	Profile
Instant Peptides 0.0	Profile
Modern Aminos 0.0	Profile
Nura Peptide 0.0	Profile
Penguin Peptides 0.0	Profile
Southern Aminos 0.0	Profile